It causes a wide range of infections such as meningitis, bacteremia,respiratory tract infections, urinary tract infections, surgical site infections, soft tissue infections, prosthesis, and catheter infections.In this article, a rare case of C. indolegenes surgical site infection following percutaneous endoscopic gastrostomy in a patienttreated for malnutrition is presented.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Chryseobacterium indologenes is a Gram-negative, immobile, aerobic, non-fermentative, oxidase-positive bacillus.
Conclusion & Impact:It causes a wide range of infections such as meningitis, bacteremia,respiratory tract infections, urinary tract infections, surgical site infections, soft tissue infections, prosthesis, and catheter infections.In this article, a rare case of C. indolegenes surgical site infection following percutaneous endoscopic gastrostomy in a patienttreated for malnutrition is presented.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
Chryseobacterium indologenes is a Gram-negative, immobile, aerobic, non-fermentative, oxidase-positive bacillus. This agent isa rarely isolated multidrug-resistant nosocomial pathogen. It causes a wide range of infections such as meningitis, bacteremia,respiratory tract infections, urinary tract infections, surgical site infections, soft tissue infections, prosthesis, and catheter infections.In this article, a rare case of C. indolegenes surgical site infection following percutaneous endoscopic gastrostomy in a patienttreated for malnutrition is presented.
🔖
Cite This Article
AYGÜL, A., YILMAZ, K. (2022). Surgical site infection associated with a rare agent,Chryseobacterium indologenes. Annals of Medical Research, Cilt: 28 - Sayı: 4, 847–849. https://ajindex.com/articles/446013
Mukerji R, Kakarala R, Smith SJ, et al. Chryseobacterium indologenes: an emerging infection in the USA. BMJ Case Rep 2016; bcr2016214486
Kirby JT, Sader HS, Walsh TR, et al. Antimicrobial susceptibility and epidemiology of a worldwide collection of Chryseobacterium spp: report from the SENTRY Antimicrobial Surveillance Program (1997- 2001). J Clin Microbiol 2004;42:445-8
Das P, Karade S, Kaur K, et al. Chryseobacterium indologenes pneumonitis in an infant: A Case Report. Clin Diagn Res 2017;1:7-8
Bhalla GS, Gupta S, Sarao MS, et al. Chryseobacterium indologenes: Case report of an emerging pathogen. JMMS 2018;20:70-2
Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing, M100-S23
Ceylan A, Guducuoglu H, Akbayram S, et al. Hidrosefalisi olan bir olguda Chryseobacterium indologenes ile ilişkili sepsis. Mikrobiyol Bul 2011;45:735-40
Douvoyiannis M, Kalyoussef S, Philip G, et al. Chryseobacterium indologenes bacteremia in an infant. Int J Infect Dis 2010;14:531-2
Hsueh PR, Teng LJ, Yang PC, et al. Increasing incidence of nosocomial Chryseobacterium indologenes infections in Taiwan. Eur J Clin Microbiol Infect Dis 1997;16:568-74
Chen FL, Wang GC, Teng SO, et al. Clinical and epidemiological features of Chryseobacterium indologenes infections: analysis of 215 cases. J Microbiol Immunol Infect 2013;46:425-32
Bellais S, Poirel L, Leotard S, et al. Genetic diversity of carbapenem-hydrolyzing metallo-beta-lactamases from Chryseobacterium (Flavobacterium) indologenes. Antimicrob Agents Chemother 2000;44:3028-34
Lin YT, Jeng YY, Lin ML, et al. Clinical and microbiological characteristics of Chryseobacterium indologenes bacteremia. J Microbiol Immunol Infect 2010;43:498-505
Nulens E, Bussels B, Bols A, et al. Recurrent bacteremia by Chryseobacterium indologenes in an oncology patient with a totally implanted intravascular device. Clin Microbiol Infect 2001;7:391-3.